- Home
- CWST vs LNTH Comparison
CWST vs LNTH Comparison
Compare CWST & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CWST | LNTH |
|---|---|---|
| Founded | 1975 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 4.4B |
| IPO Year | 1997 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CWST | LNTH |
|---|---|---|
| Price | $100.37 | $66.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 6 |
| Target Price | ★ $118.67 | $78.00 |
| AVG Volume (30 Days) | ★ 1.5M | 1.2M |
| Earning Date | 10-30-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 102.54 | N/A |
| EPS | 0.24 | ★ 2.39 |
| Revenue | ★ $1,795,272,000.00 | $1,525,933,000.00 |
| Revenue This Year | $20.34 | $0.01 |
| Revenue Next Year | $7.68 | $1.24 |
| P/E Ratio | $409.85 | ★ $27.55 |
| Revenue Growth | ★ 20.54 | 1.95 |
| 52 Week Low | $82.22 | $47.25 |
| 52 Week High | $121.24 | $111.29 |
Technical Indicators
Market Signals| Indicator | CWST | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 63.10 | 67.34 |
| Support Level | $98.40 | $64.13 |
| Resistance Level | $101.93 | $67.01 |
| Average True Range (ATR) | 2.39 | 2.17 |
| MACD | 0.13 | 0.32 |
| Stochastic Oscillator | 76.06 | 84.68 |
Price Performance
Historical ComparisonAbout CWST Casella Waste Systems Inc.
Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.